Measuring Metabolic Syndrome (MetS) in Community Pharmacies: A Cross- Sectional Descriptive Study in Malaysia

Presentation Number: MON 277
Date of Presentation: April 3rd, 2017

Rohit Kumar Verma*1, Paraidathathu Thomas2 and Nur Akmar Taha3
1International Medical University, Malaysia, Kualalumpur, Malaysia, 2Taylor’s University, Malaysia, 3National University of Malaysia


Background: Metabolic syndrome (MetS) is becoming more common due to a rise in obesity rates among adults. Malaysia has a much higher prevalence of MetS compared with other Asian countries and, unless there is immediate intervention to reduce risk factors, this may pose serious implications on the country's healthcare costs and services. There is lack of information about the role of community pharmacists in the care of patients with the MetS.


The aim of this study is to assess community pharmacies led services available to measure MetS.


550 community pharmacies from six states of Malaysia.


A descriptive, cross-sectional study was performed on randomly selected sample of 550 community pharmacists. Data were collected via self-developed, reliable and validated questionnaire. The information was gathered using a data collection form, containing 8 items, measured on a five-point Likert Scale. Ethics approval (NF-016-14) was obtained from the ethics committee of the UKM Medical Centre, Kuala Lumpur, Malaysia.

Main outcome measures

Majority of community pharmacists providing services to diagnose MetS.


Out of 2,205 community pharmacies in Malaysia, 550 pharmacists who worked in these pharmacies across six states (Selangor, Kuala-Lumpur, Pulau Pinang, Johor, Sabah, and Melaka) of Malaysia participated in this study. A large number (93.27%) respondents provided body mass index (BMI) calculation for subject while 89.27% and 88.54% of pharmacies provided waist measurement and body fat percentage. Majority (95.81%) agreed that they provided measurement of blood pressure, and 92.36% respondents provided blood cholesterol measurement. Blood glucose monitoring was provided by 95.09% of pharmacies.


To the author knowledge this is the first study conducted in Malaysia by using largest number of community pharmacists as respondents. Data revealed significant number of pharmacies provided services which could be helpful to diagnose MetS. Offered services by community pharmacists can be integrate with healthcare system to control emerging MetS related events.

Keywords: metabolic syndrome, community pharmacists, Diagnosis services, Malaysia


Nothing to Disclose: RKV, PT, NAT